Protalix BioTherapeutics
PLX
#8429
Rank
โ‚น15.08 B
Marketcap
โ‚น204.89
Share price
1.72%
Change (1 day)
57.00%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -โ‚น0.65 Billion

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are โ‚น45.66 Million. In 2023 the company made an earning of โ‚น1.01 Billion, an increase over its 2022 earnings that were of -โ‚น1.03 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น0.65 Billion-163.45%
2023 โ‚น1.01 B-199.05%
2022 -โ‚น1.03 Billion-40.38%
2021 -โ‚น1.73 Billion-732.31%
2020 โ‚น0.27 B-130.53%
2019 -โ‚น0.9 Billion189.85%
2018 -โ‚น0.31 Billion-95.29%
2017 -โ‚น6.54 Billion308.12%
2016 -โ‚น1.61 Billion-32.37%
2015 -โ‚น2.37 Billion10.11%
2014 -โ‚น2.15 Billion-7.59%
2013 -โ‚น2.33 Billion
2011 -โ‚น2.7 Billion-19.39%
2010 -โ‚น3.35 Billion20.87%
2009 -โ‚น2.77 Billion32.26%
2008 -โ‚น2.09 Billion-5.46%
2007 -โ‚น2.22 Billion
2004 -โ‚น14.32 Million12.35%
2003 -โ‚น12.75 Million-11.1%
2002 -โ‚น14.34 Million-57.03%
2001 -โ‚น33.36 Million1.03%
2000 -โ‚น33.02 Million-53.22%
1999 -โ‚น70.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น5.91 Billion 781.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น56.77 B-8,564.81%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น600.22 B-89,594.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น36.30 B-5,513.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel